Majority of Americans Unaware That Early-Stage Prostate Cancer Often Shows No Symptoms

A recent comprehensive survey conducted by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) has revealed a significant gap in awareness among Americans regarding prostate cancer. The survey found that a striking 80% of respondents did not know that early-stage prostate cancer frequently presents without noticeable symptoms and is commonly diagnosed through blood testing rather than physical signs.

Prostate cancer remains one of the most prevalent cancers affecting men in the United States, with over 300,000 new cases reported annually, according to the National Cancer Institute. It primarily affects men over the age of 50. Experts emphasize that early detection through regular screening is crucial because when caught early, prostate cancer is highly treatable.

"Prostate cancer originates in the prostate gland and, especially in the early stages, usually doesn't cause symptoms, which makes regular screenings vital," explained Dr. Edmund Folefac, a medical oncologist at OSUCCC–James.

The survey also highlighted that more than half of Americans (59%) are unaware that issues such as sexual dysfunction can be symptoms of prostate cancer. Interestingly, among different racial groups, Black adults demonstrated a better recognition of some lesser-known symptoms like fatigue and weight loss, which can be associated with the disease.

Understanding risk factors is equally important. Dr. Folefac stressed the significance of knowing one’s family medical history because men with relatives diagnosed with prostate cancer are at higher risk and should consider starting screenings earlier and more regularly.

Current guidelines recommend that men begin prostate cancer screening at age 50, but awareness remains a challenge. The survey, which involved 1,004 participants aged 18 and older, was carried out via web and telephone from August 1 to August 4, 2025. It used a probabilistic sampling method to ensure representation of the U.S. adult population, with a margin of error of plus or minus 3.5%.

Given that early detection greatly improves treatment options, increasing awareness about the asymptomatic nature of early-stage prostate cancer is vital. Regular screening and discussing personal risk factors with healthcare providers remain key strategies for combating this disease.

(Source: https://medicalxpress.com/news/2025-08-survey-reveals-americans-dont-early.html)